BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 32170764)

  • 1. Differential expression analysis of clear cell renal cell carcinomas in The Cancer Genome Atlas distinguishes an aggressive subset enriched with chromosomes 7 and 12 gains.
    Pan CC; Yeh YC; Wang YC; Chang YH
    Histopathology; 2020 Jun; 76(7):950-958. PubMed ID: 32170764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel evolution of tumour subclones mimics diversity between tumours.
    Martinez P; Birkbak NJ; Gerlinger M; McGranahan N; Burrell RA; Rowan AJ; Joshi T; Fisher R; Larkin J; Szallasi Z; Swanton C
    J Pathol; 2013 Aug; 230(4):356-64. PubMed ID: 23716380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
    Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
    PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
    J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
    Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
    Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features.
    Ren Q; Wang L; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
    Am J Surg Pathol; 2018 Jun; 42(6):767-777. PubMed ID: 29462091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States.
    Wozniak MB; Le Calvez-Kelm F; Abedi-Ardekani B; Byrnes G; Durand G; Carreira C; Michelon J; Janout V; Holcatova I; Foretova L; Brisuda A; Lesueur F; McKay J; Brennan P; Scelo G
    PLoS One; 2013; 8(3):e57886. PubMed ID: 23526956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations in renal cell carcinoma with rhabdoid differentiation.
    Perrino CM; Hucthagowder V; Evenson M; Kulkarni S; Humphrey PA
    Hum Pathol; 2015 Jan; 46(1):9-16. PubMed ID: 25439741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets.
    Verbiest A; Van Hoef V; Rodriguez-Antona C; García-Donas J; Graña-Castro O; Albersen M; Baldewijns M; Laenen A; Roussel E; Schöffski P; Wozniak A; Caruso S; Couchy G; Zucman-Rossi J; Beuselinck B
    PLoS One; 2020; 15(9):e0238809. PubMed ID: 32915890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
    Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
    Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma.
    Sanjmyatav J; Junker K; Matthes S; Muehr M; Sava D; Sternal M; Wessendorf S; Kreuz M; Gajda M; Wunderlich H; Schwaenen C
    J Urol; 2011 Nov; 186(5):2078-83. PubMed ID: 21944119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.
    Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
    Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J
    Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
    Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.